Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
Clinical trial NCT04006210 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04006210
- Sponsor
- NeuroDerm Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-30
- Primary completion
- 2022-11-01
- Enrollment
- 381
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.